Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Gpr132 | Rat | (-)-demecolcine | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of GPR132 mRNA | CTD | PMID:23649840 | Gpr132 | Rat | 17beta-estradiol | multiple interactions | ISO | GPR132 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of GPR132 mRNA | CTD | PMID:30165855 | Gpr132 | Rat | 17beta-estradiol | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Estradiol results in increased expression of GPR132 mRNA | CTD | PMID:31614463 | Gpr132 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Gpr132 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of GPR132 mRNA | CTD | PMID:18648102 | Gpr132 | Rat | 5-fluorouracil | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of GPR132 mRNA | CTD | PMID:16584549 | Gpr132 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GPR132 mRNA | CTD | PMID:31881176 | Gpr132 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of GPR132 mRNA | CTD | PMID:28959563 | Gpr132 | Rat | aflatoxin B1 | decreases methylation | ISO | GPR132 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of GPR132 intron | CTD | PMID:30157460 | Gpr132 | Rat | aflatoxin B1 | increases methylation | ISO | GPR132 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of GPR132 promoter | CTD | PMID:30157460 | Gpr132 | Rat | all-trans-retinoic acid | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GPR132 mRNA | CTD | PMID:33167477 | Gpr132 | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of GPR132 mRNA | CTD | PMID:35163327 | Gpr132 | Rat | antirheumatic drug | decreases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of GPR132 mRNA | CTD | PMID:24449571 | Gpr132 | Rat | aristolochic acid A | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of GPR132 mRNA | CTD | PMID:33212167 | Gpr132 | Rat | benzene | affects expression | ISO | GPR132 (Homo sapiens) | 6480464 | Benzene affects the expression of GPR132 mRNA | CTD | PMID:21147609 | Gpr132 | Rat | benzo[a]pyrene | increases methylation | ISO | GPR132 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of GPR132 5' UTR | CTD | PMID:27901495 | Gpr132 | Rat | benzo[a]pyrene | affects methylation | ISO | GPR132 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GPR132 promoter | CTD | PMID:27901495 | Gpr132 | Rat | beta-lapachone | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of GPR132 mRNA | CTD | PMID:38218311 | Gpr132 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GPR132 mRNA | CTD | PMID:25181051 | Gpr132 | Rat | bisphenol A | increases expression | ISO | Gpr132 (Mus musculus) | 6480464 | bisphenol A results in increased expression of GPR132 mRNA | CTD | PMID:38701888 | Gpr132 | Rat | bisphenol A | decreases expression | ISO | GPR132 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of GPR132 mRNA | CTD | PMID:31715268 | Gpr132 | Rat | bisphenol A | decreases methylation | ISO | Gpr132 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of GPR132 promoter | CTD | PMID:27312807 | Gpr132 | Rat | bisphenol A | decreases expression | ISO | Gpr132 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GPR132 mRNA | CTD | PMID:25594700 | Gpr132 | Rat | buta-1,3-diene | decreases expression | ISO | Gpr132 (Mus musculus) | 6480464 | 1,3-butadiene results in decreased expression of GPR132 mRNA | CTD | PMID:29038090 | Gpr132 | Rat | butanal | decreases expression | ISO | GPR132 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of GPR132 mRNA | CTD | PMID:26079696 | Gpr132 | Rat | cadmium dichloride | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of GPR132 mRNA | CTD | PMID:38568856 | Gpr132 | Rat | camptothecin | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of GPR132 mRNA | CTD | PMID:38460933 | Gpr132 | Rat | capsaicin | decreases expression | ISO | Gpr132 (Mus musculus) | 6480464 | Capsaicin results in decreased expression of GPR132 mRNA | CTD | PMID:19602228 | Gpr132 | Rat | carbon nanotube | affects expression | ISO | Gpr132 (Mus musculus) | 6480464 | Nanotubes, Carbon affects the expression of GPR132 mRNA | CTD | PMID:25554681 | Gpr132 | Rat | carrageenan | increases expression | ISO | Gpr132 (Mus musculus) | 6480464 | Carrageenan results in increased expression of GPR132 mRNA | CTD | PMID:19602228 | Gpr132 | Rat | chlordecone | decreases expression | ISO | Gpr132 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of GPR132 mRNA | CTD | PMID:33711761 | Gpr132 | Rat | cisplatin | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GPR132 mRNA | CTD | PMID:27594783 | Gpr132 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of GPR132 mRNA | CTD | PMID:26033743 | Gpr132 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of GPR132 mRNA | CTD | PMID:26033743 | Gpr132 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of GPR132 mRNA | CTD | PMID:27523638 | Gpr132 | Rat | Dibutyl phosphate | affects expression | ISO | GPR132 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of GPR132 mRNA | CTD | PMID:37042841 | Gpr132 | Rat | dimethylarsinic acid | multiple interactions | ISO | Gpr132 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Gpr132 | Rat | diquat | decreases expression | ISO | Gpr132 (Mus musculus) | 6480464 | Diquat results in decreased expression of GPR132 mRNA | CTD | PMID:36851058 | Gpr132 | Rat | disodium selenite | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of GPR132 mRNA | CTD | PMID:18175754 | Gpr132 | Rat | ethyl methanesulfonate | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GPR132 mRNA | CTD | PMID:23649840 | Gpr132 | Rat | formaldehyde | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GPR132 mRNA | CTD | PMID:23649840 | Gpr132 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of GPR132 mRNA | CTD | PMID:22079235 | Gpr132 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of GPR132 mRNA | CTD | PMID:33387578 | Gpr132 | Rat | GSK-J4 | decreases expression | ISO | GPR132 (Homo sapiens) | 6480464 | GSK-J4 results in decreased expression of GPR132 mRNA | CTD | PMID:29301935 | Gpr132 | Rat | lead diacetate | multiple interactions | ISO | GPR132 (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of GPR132 mRNA | CTD | PMID:22839698 | Gpr132 | Rat | lipopolysaccharide | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of GPR132 mRNA | CTD | PMID:35811015 | Gpr132 | Rat | lipopolysaccharide | multiple interactions | ISO | GPR132 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR132 mRNA | CTD | PMID:35811015 | Gpr132 | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of GPR132 gene | CTD | PMID:35440735 | Gpr132 | Rat | methyl methanesulfonate | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GPR132 mRNA | CTD | PMID:23649840 | Gpr132 | Rat | methylarsonic acid | multiple interactions | ISO | Gpr132 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Gpr132 | Rat | nickel atom | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Nickel results in increased expression of GPR132 mRNA | CTD | PMID:23195993 | Gpr132 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | GPR132 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR132 mRNA | CTD | PMID:35811015 | Gpr132 | Rat | silicon dioxide | decreases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of GPR132 mRNA | CTD | PMID:25895662 | Gpr132 | Rat | sodium arsenate | multiple interactions | ISO | Gpr132 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Gpr132 | Rat | sodium arsenite | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GPR132 mRNA | CTD | PMID:17879257 | Gpr132 | Rat | sodium arsenite | multiple interactions | ISO | Gpr132 (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Gpr132 | Rat | sodium arsenite | decreases expression | ISO | Gpr132 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of GPR132 mRNA | CTD | PMID:39515575 | Gpr132 | Rat | sodium fluoride | increases expression | ISO | Gpr132 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of GPR132 mRNA | CTD | PMID:27862939 | Gpr132 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GPR132 mRNA | CTD | PMID:34492290 | Gpr132 | Rat | titanium dioxide | decreases expression | ISO | Gpr132 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of GPR132 mRNA | CTD | PMID:29264374 | Gpr132 | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of GPR132 mRNA | CTD | PMID:33387578 | Gpr132 | Rat | triphenyl phosphate | affects expression | ISO | GPR132 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of GPR132 mRNA | CTD | PMID:37042841 | Gpr132 | Rat | triptonide | increases expression | ISO | Gpr132 (Mus musculus) | 6480464 | triptonide results in increased expression of GPR132 mRNA | CTD | PMID:33045310 | Gpr132 | Rat | valproic acid | increases methylation | ISO | GPR132 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of GPR132 gene | CTD | PMID:29154799 | Gpr132 | Rat | vincristine | increases expression | ISO | GPR132 (Homo sapiens) | 6480464 | Vincristine results in increased expression of GPR132 mRNA | CTD | PMID:23649840 | Gpr132 | Rat | zinc protoporphyrin | multiple interactions | ISO | GPR132 (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of GPR132 mRNA | CTD | PMID:22839698 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















